News

Medicare

Reuters | Equities.com |

The Biden administration is set to unveil a plan that supports legislation to empower the U.S. federal government to negotiate drug prices in Medicare and pass along the benefits to the private sector, the Wall Street Journal reported on Thursday.

The COVID-19 outbreak, which has upended the U.S. economy and so far killed about 649,299 people in the country, has drawn renewed attention to healthcare costs.